Related references
Note: Only part of the references are listed.Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy
Massimo Franchini et al.
VOX SANGUINIS (2021)
Convalescent plasma as a potential therapy for COVID-19
Long Chen et al.
LANCET INFECTIOUS DISEASES (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light
Markus Eickmann et al.
VOX SANGUINIS (2020)
Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19
Libo Zhang et al.
AGING-US (2020)
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Dominic Wichmann et al.
ANNALS OF INTERNAL MEDICINE (2020)
Efficacy of therapeutic plasma exchange in severe COVID-19 patients
Li Zhang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Association between ABO blood groups and risk of SARS-CoV-2 pneumonia
Juyi Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
Jie Ma et al.
CLINICAL IMMUNOLOGY (2020)
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Li Guo et al.
CLINICAL INFECTIOUS DISEASES (2020)
Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019
Xiaohua Chen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
Olivia A. Vogel et al.
FRONTIERS IN MICROBIOLOGY (2020)
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol
Cesare Perotti et al.
INTERNAL AND EMERGENCY MEDICINE (2020)
Successful treatment of plasma exchange followed by intravenous immunogloblin in a critically ill patient with 2019 novel coronavirus infection
Hua Shi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Get rid of the bad first: Therapeutic plasma exchange with convalescent for severe COVID-19
Selman Kesici et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019
Qing-Lei Zeng et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Treatment with convalescent plasma for COVID-19 patients in Wuhan, China
Mingxiang Ye et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
COVID-19 convalescent plasma: phase 2
C. Michael Knudson et al.
TRANSFUSION (2020)
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design
Paul Barone et al.
TRANSFUSION (2020)
Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike
J. Seghatchian et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma
Yujie Kong et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis
Olgu Erkin Cinar et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment
Shawn D. Keil et al.
VOX SANGUINIS (2020)
ABO blood group predisposes to COVID-19 severity and cardiovascular diseases
Xiaofeng Dai
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism
Joris R. Delanghe et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2
Adrien Breiman et al.
PLOS PATHOGENS (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat et al.
NATURE MEDICINE (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
Wei Cao et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment
Takahiko Koyama et al.
PATHOGENS (2020)
Coronavirus Disease 2019-COVID-19
Kuldeep Dhama et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Convalescent plasma therapy: Helpful treatment of COVID-19 in a kidney transplant recipient presenting with serve clinical manifestation and complex complications
Jipin Jiang et al.
CLINICAL TRANSPLANTATION (2020)
Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
Xinyi Xia et al.
BLOOD (2020)
Use of convalescent plasma in hospitalized patients with COVID-19: case series
Livia Hegerova et al.
BLOOD (2020)
COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma
Alex Niu et al.
BONE MARROW TRANSPLANTATION (2020)
Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery
Evangeline Clark et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Anti-A isohaemagglutinin titres and SARS-CoV-2 neutralization: implications for children and taconvalescent plasma selection
Daniele Focosi
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma
Estefania Mira et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Michael J. Joyner et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
Bicheng Zhang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
Matthew R. Davis et al.
INFECTIOUS DISEASES AND THERAPY (2020)
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
Michael J. Joyner et al.
MAYO CLINIC PROCEEDINGS (2020)
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
David Ellinghaus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY
Juan C. Olivares-Gazca et al.
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION (2020)
The true historical origin of convalescent plasma therapy
Piero Marson et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia
Mehmet Ali Erkurt et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia
Magdalena Figlerowicz et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients
Irma Convertino et al.
CRITICAL CARE (2020)
The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure
Philip Keith et al.
SAGE OPEN MEDICAL CASE REPORTS (2020)
Severe refractory COVID-19 patients responding to convalescent plasma; A case series
Hadi Mohammed Abdullah et al.
ANNALS OF MEDICINE AND SURGERY (2020)
Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles
Jae Hyoung Im et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Use of Convalescent Plasma Therapy in Two COVID-19 Patients With Acute Respiratory Distress Syndrome in Korea
Jin Young Ahn et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Therapeutic strategies to target the Ebola virus life cycle
Thomas Hoenen et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Chikungunya Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention
Francesco Vairo et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)
Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light
Salwa I. Hindawi et al.
TRANSFUSION (2018)
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
Jae-Hoon Ko et al.
ANTIVIRAL THERAPY (2018)
Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively
Markus Eickmann et al.
TRANSFUSION (2018)
Pork products associated with human infection caused by an emerging phylotype of hepatitis E virus in England and Wales
B. Said et al.
EPIDEMIOLOGY AND INFECTION (2017)
Hepatitis E risks: pigs or blood-that is the question
Richard S. Tedder et al.
TRANSFUSION (2017)
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015
Pyoeng Gyun Choe et al.
EMERGING INFECTIOUS DISEASES (2017)
Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment
Shawn D. Keil et al.
TRANSFUSION (2016)
Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome
Sejong Chun et al.
ANNALS OF LABORATORY MEDICINE (2016)
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
Yaseen M. Arabi et al.
EMERGING INFECTIOUS DISEASES (2016)
Minipool Caprylic Acid Fractionation of Plasma Using Disposable Equipment: A Practical Method to Enhance Immunoglobulin Supply in Developing Countries
Magdy El-Ekiaby et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
Yaseen Arabi et al.
SPRINGERPLUS (2015)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Sheng-Fan Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Heat inactivation of the Middle East respiratory syndrome coronavirus
India Leclercq et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2014)
Hepatitis E virus in blood components: a prevalence and transmission study in southeast England
Patricia E. Hewitt et al.
LANCET (2014)
Ebola virus convalescent blood products: Where we are now and where we may need to go
Thierry Burnouf et al.
TRANSFUSION AND APHERESIS SCIENCE (2014)
First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood
Weimin Zhou et al.
BMC INFECTIOUS DISEASES (2013)
Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection
Hoi K. Wong et al.
TRANSFUSION (2010)
Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system
M. El-Ekiaby et al.
TRANSFUSION MEDICINE (2010)
Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance
M. Radosevich et al.
VOX SANGUINIS (2010)
Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at-30°C
D. J. Bihm et al.
VOX SANGUINIS (2010)
Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies
Patrice Guillon et al.
GLYCOBIOLOGY (2008)
Epitopes required for antibody-dependent enhancement of Ebola virus infection
Ayato Takada et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-Mediated severe acute respiratory syndrome coronavirus entry
Dong P. Han et al.
JOURNAL OF VIROLOGY (2007)
Duration of antibody responses after severe acute respiratory syndrome
Li-Ping Wu et al.
EMERGING INFECTIOUS DISEASES (2007)
Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products
Miriam E. R. Darnell et al.
TRANSFUSION (2006)
Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function
Yasmin Singh et al.
TRANSFUSION (2006)
Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome
W Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
N Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
KM Yeh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63
KH Chan et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2005)
Influence of FcγRIIA and MBL polymorphisms on severe acute respiratory syndrome
FF Yuan et al.
TISSUE ANTIGENS (2005)
Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates
D Pinna et al.
TRANSFUSION MEDICINE (2005)
Purification of severe acute respiratory syndrome hyperimmune globulins for intravenous injection from convalescent plasma
Z Zhang et al.
TRANSFUSION (2005)
HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation
SJD Neil et al.
BLOOD (2005)
SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation
HF Rabenau et al.
BIOLOGICALS (2005)
ABO blood group and susceptibility to severe acute respiratory syndrome
YF Cheng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
SARS-coronavirus replication in human peripheral monocytes/macrophages
M Yilla et al.
VIRUS RESEARCH (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
YOY Soo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Heat sensitivity of a SARS-associated coronavirus introduced into plasma products
M Yunoki et al.
VOX SANGUINIS (2004)
Antibody-dependent enhancement of Ebola virus infection
A Takada et al.
JOURNAL OF VIROLOGY (2003)
Nanofiltration of single plasma donations: feasibility study
T Burnouf et al.
VOX SANGUINIS (2003)
Effect of multiple freeze-thaw cycles on detection of measles, mumps, and rubella virus antibodies
NA Pinsky et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2003)
Enveloped virus inactivation by caprylate: A robust alternative to solvent-detergent treatment in plasma derived intermediates
M Korneyeva et al.
BIOLOGICALS (2002)
Inactivation of lipid enveloped viruses by octanoic acid treatment of immunoglobulin solution
H Dichtelmüller et al.
BIOLOGICALS (2002)
Passive transfer of scrub typhus plasma to patients with AIDS: a descriptive clinical study
G Watt et al.
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS (2001)
Virucidal heat-treatment of single plasma units: a potential approach for developing countries
HA Goubran et al.
HAEMOPHILIA (2000)
Share Paper
